SCHEMBL10163178

SCHEMBL10163178

COc1ccc(Br)c(C(=O)Nc2cccc3c(-c4ccc(N(C)C)cc4)c(OC)c(OC)cc23)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.42
ALDH1A1 P00352 6/20 0.42
MAPK1 P28482 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
MAPK14 Q16539 2/20 0.42
GFER P55789 2/20 0.41
LMNA P02545 2/20 0.41
MCL1 Q07820 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 3/20 0.38
GAA P10253 2/20 0.37
TSHR P16473 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
PKM P14618 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10161769 0.90 ABCB1 (0.44) MAPTSMN1; SMN2LMNAL3MBTL1HSD17B10
SCHEMBL10163103 0.89 LMNA (0.43) MAPTSMN1; SMN2LMNAL3MBTL1HSD17B10
SCHEMBL13283974 0.88 SMN1; SMN2 (0.45) MAPTALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL10132784 0.88 PKM (0.38) MAPTALDH1A1MAPK1SMN1; SMN2RAB9A
SCHEMBL10163297 0.83 TUBB4A (0.42) MAPTALDH1A1SMN1; SMN2RAB9ALMNA
SCHEMBL10163293 0.83 TUBB4A (0.43) MAPTSMN1; SMN2LMNAL3MBTL1HSD17B10
SCHEMBL10163172 0.83 ABCB1 (0.47) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL10132642 0.82 SMO (0.43) ALDH1A1SMN1; SMN2LMNAL3MBTL1HSD17B10
SCHEMBL10163168 0.82 GAA (0.39) MAPTALDH1A1MAPK1SMN1; SMN2RAB9A
SCHEMBL10132694 0.82 PKM (0.42) SMN1; SMN2LMNAL3MBTL1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH MAPT 4875/4885ALDH1A1 3095/4885MAPK1 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.